C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/522 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2670202
The present invention relates to compounds of formula (I) and the use of these compounds as pharmaceuticals, e.g. in preventing or treating a CXCR2 receptor mediated condition or disease.
La présente invention concerne des composés de formule (I) et leur utilisation comme produits pharmaceutiques, p. ex. en prévention ou traitement d'une affection ou d'une maladie à médiation par le récepteur CXCR2.
Porter David
Press Neil John
Spanka Carsten
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1450687